Related Experiment Video
Updated: Jul 18, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Maintaining the CRRT circuit: non-anticoagulant alternatives
1Intensive Care Unit, Royal Perth Hospital, WA.
Summary
Optimizing continuous renal replacement therapy (CRRT) circuit life involves using biocompatible materials and managing blood flow to prevent clotting. Strategies like pre-dilution and monitoring air exposure significantly extend circuit duration beyond anticoagulation alone.
Area of Science:
- Nephrology
- Critical Care Medicine
- Biomedical Engineering
Background:
- Continuous renal replacement therapy (CRRT) requires effective clotting prevention for optimal patient management.
- Circuit longevity is crucial for maintaining solute clearance, electrolyte balance, and fluid control during CRRT.
Purpose of the Study:
- To identify strategies for prolonging the functional lifespan of CRRT circuits.
- To review components and design features that influence CRRT circuit patency.
Main Methods:
- Literature review focusing on CRRT circuit design, materials, and operational strategies.
- Analysis of factors affecting blood flow, viscosity, and air-blood contact within the CRRT circuit.
Main Results:
- Biocompatible materials and designs minimizing turbulent blood flow are essential for CRRT circuit longevity.
- Pre-dilution reduces blood viscosity and haemoconcentration, delaying clot formation.
- Monitoring venous air traps and ensuring adequate vascular access minimize circuit clotting.
- Nursing staff competency and catheter design also impact circuit life.
Conclusions:
- Specific CRRT application measures, beyond anticoagulation, can significantly influence circuit life and clotting.
- Evidence-based guidelines incorporating these strategies are needed to enhance CRRT circuit durability.
- Further research is needed to determine the impact of different CRRT modes on circuit longevity.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.